UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
report (Date of earliest event reported) October 19,
2007
TEMPUR-PEDIC
INTERNATIONAL INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
001-31922
|
33-1022198
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
1713
Jaggie Fox Way
Lexington,
Kentucky 40511
(Address
of principal executive offices) (Zip Code)
(800)
878-8889
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation
of
the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02. Results from Operations and Financial
Condition
In
response to investor inquiries,
Tempur-Pedic International Inc. (the “Company”) is providing additional
information related to its previously disclosed Australian
acquisition.
On
September 3, 2007, the Company
acquired the distribution rights and certain assets pertaining to its third
party distribution business in Australia. The consideration paid was
$4.6 million.
Prior
to the acquisition, for the 8
months ended August 31, 2007, Australia contributed approximately $2.5 million
to the Company’s net sales. For the full year 2006, Australia
contributed $3.5 million to the Company’s net sales.
The
information in this report shall
not be deemed to be “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to
the liability of that section, and shall not be incorporated by reference into
any registration statement or other document filed under the Securities Act
of
1933, as amended, or the Exchange Act, except as shall be expressly set forth
by
specific reference in such filing.
Item
7.01. Regulation FD Disclosure
The
information furnished under Item
2.02 of this Form 8-K is hereby incorporated by reference under this Item 7.01
as if fully set forth herein.
Item
9.01. Financial Statements and Exhibits
(d) Exhibits
None.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Date: October 19,
2007
|
|||
| Tempur-Pedic International Inc. | |||
|
|
By:
|
/s/ H. Thomas Bryant | |
| Name: H. Thomas Bryant | |||
| Title: President and Chief Executive Officer | |||